Nicotine swap helps smokers slash cigarettes in half
NCT ID NCT06554873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether smokers who quickly respond to nicotine alternatives (like patches, e-cigarettes, or pouches) can keep smoking less or stop entirely for 6 months. 150 healthy adult smokers who reduced their smoking by at least half within 2 weeks were followed. The goal was to see if using these products long-term helps maintain lower smoking levels or quitting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
150 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Dec 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy, adult smoker of combustible cigarettes. * Age 22 to 65 years at time of screening (verified by government issued ID). * Smoke cigarettes for ≥12 months prior to screening. * Currently smokes at least 10 tobacco cigarettes per day. * Screening eCO ≥ 10 ppm. * Voluntarily provides consent for participation by signing the informed consent form (ICF). * Willing and able to comply with study requirements. Exclusion Criteria: * Unable to read, speak or understand English * Has a history or presence of clinically significant medical or psychiatric disease, or any other condition that would in the PI's judgement jeopardize the safety of the participant, impair the participant's ability to comply with study procedures, or impact the validity of the study results. * Has used nicotine-containing e-cigarettes (or vapes) or any nicotine replacement therapy (nicotine patch, nicotine gum, nicotine spray, nicotine inhaler, nicotine lozenge) or prescription smoking cessation medications, including, but not limited to, varenicline (Chantix\*) or bupropion (Zyban®) within the past 30 days. If female, participant is pregnant, nursing, or intends to become pregnant during the time period from screening through the end of study. * Has participated in a research study about tobacco products or ENDS within the past 30 days. * Has participated in a smoking cessation or nicotine switching research study in the past year. * Smokes or vapes cannabis more than once a week. * Cannabis Use Disorder Identification Test-Revised (CUDIT-R) score of 8 or greater. * Heterosexually active participants of Childbearing Potential (not sterilized by tubal ligation, oophorectomy, hysterectomy, or other surgical methods, or post-menopausal) that do not agree to practice medically appropriate methods of birth control (or remain abstinent) during the course of the trial. Medically acceptable methods of birth control include: vasectomy, vaginal diaphragm with spermicide, intrauterine device, hormonal birth control (oral, injected, or implanted), condom with spermicide, or sponge with spermicide. * Subgroup enrollment is complete.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Harm reduction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rose Research Center
Charlotte, North Carolina, 28262, United States
-
Rose Research Center
Raleigh, North Carolina, 27617, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and wearables team up to help latinos quit smoking and get moving
- Can an AI chatbot help cancer patients kick the habit?
- Does the clock matter? scientists randomize when Quit-Smoking chatbots ping you
- Can a WhatsApp message help smokers quit?
- Can a brain scan tailor TMS to quiet cigarette cravings?
- Practice quitting: a new way to help smokers who Aren't ready to stop?